PY2089151A - Compuestos y composiciones para tratar afecciones asociadas con la actividad de sting - Google Patents
Compuestos y composiciones para tratar afecciones asociadas con la actividad de stingInfo
- Publication number
- PY2089151A PY2089151A PY202002089151A PY2089151A PY2089151A PY 2089151 A PY2089151 A PY 2089151A PY 202002089151 A PY202002089151 A PY 202002089151A PY 2089151 A PY2089151 A PY 2089151A PY 2089151 A PY2089151 A PY 2089151A
- Authority
- PY
- Paraguay
- Prior art keywords
- sting
- compositions
- activity
- compounds
- conditions associated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962955853P | 2019-12-31 | 2019-12-31 | |
| US202063090547P | 2020-10-12 | 2020-10-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PY2089151A true PY2089151A (es) | 2022-05-11 |
Family
ID=74550729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PY202002089151A PY2089151A (es) | 2019-12-31 | 2020-12-30 | Compuestos y composiciones para tratar afecciones asociadas con la actividad de sting |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230115274A1 (https=) |
| EP (1) | EP4085061A1 (https=) |
| JP (1) | JP2023509421A (https=) |
| CN (1) | CN115279770A (https=) |
| PY (1) | PY2089151A (https=) |
| TW (1) | TW202136255A (https=) |
| UY (1) | UY39005A (https=) |
| WO (1) | WO2021138419A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120004785A (zh) | 2018-07-03 | 2025-05-16 | 诺华制药股份有限公司 | 用于治疗与sting活性有关的疾病的化合物和组合物 |
| JP2024500874A (ja) | 2020-12-22 | 2024-01-10 | アイエフエム デュー インコーポレイテッド | がんを処置する方法 |
| US20240060982A1 (en) | 2020-12-22 | 2024-02-22 | Ifm Due, Inc. | Methods of treating cancer |
| EP4267129A1 (en) | 2020-12-22 | 2023-11-01 | IFM Due, Inc. | Methods of treating cancer |
| EP4267128A1 (en) | 2020-12-22 | 2023-11-01 | IFM Due, Inc. | Methods of treating cancer |
| JP2024502470A (ja) * | 2021-01-08 | 2024-01-19 | アイエフエム デュー インコーポレイテッド | Ｓｔｉｎｇ活性に関連する状態を治療するための化合物および組成物 |
| EP4274824A1 (en) | 2021-01-08 | 2023-11-15 | IFM Due, Inc. | Heterobicyclic compounds having an urea or analogue and their compositions for treating conditions associated with sting activity |
| IL310724A (en) | 2021-08-10 | 2024-04-01 | Ifm Due Inc | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH STING ACTIVITY |
| CN119677718A (zh) * | 2022-08-11 | 2025-03-21 | 杭州中美华东制药有限公司 | 具有sting抑制作用的酰胺类化合物及其药物组合物和用途 |
| WO2024064358A1 (en) | 2022-09-23 | 2024-03-28 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
| WO2024089155A1 (en) * | 2022-10-28 | 2024-05-02 | Boehringer Ingelheim International Gmbh | Heterocyclic compounds as sting antagonists |
| CN117756698A (zh) * | 2022-12-16 | 2024-03-26 | 中国药科大学 | 脲类化合物及其作为sting抑制剂的医药用途 |
| CN116023321B (zh) * | 2022-12-30 | 2024-11-29 | 中国药科大学 | Sting抑制剂前药及其医药用途 |
| WO2025228899A1 (en) | 2024-04-30 | 2025-11-06 | Boehringer Ingelheim International Gmbh | Further heterocyclic compounds as sting antagonists and the use thereof as medicament |
| US20250333414A1 (en) | 2024-04-30 | 2025-10-30 | Boehringer Ingelheim International Gmbh | Hetaryl substituted indazoles and benzimidazoles as sting antagonists and the use thereof as medicament |
| WO2025228900A1 (en) | 2024-04-30 | 2025-11-06 | Boehringer Ingelheim International Gmbh | Arylamide substituted indazoles and the use thereof as medicament |
| US20250333398A1 (en) | 2024-04-30 | 2025-10-30 | Boehringer Ingelheim International Gmbh | Monoaryl and hetaryl substituted indazoles and benzimidazoles as sting antagonists and the use thereof as medicament |
| WO2025228902A1 (en) | 2024-04-30 | 2025-11-06 | Boehringer Ingelheim International Gmbh | Heterocyclic acids as sting antagonists and the use thereof as medicament |
| WO2025228889A1 (en) | 2024-04-30 | 2025-11-06 | Boehringer Ingelheim International Gmbh | Monoarylic heterocyclic compounds as sting antagonists and the use thereof as medicament |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7927613B2 (en) | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
| EP1847541A4 (en) * | 2005-02-03 | 2009-12-30 | Takeda Pharmaceutical | CONDENSED PYRIMIDINE DERIVATIVE AND USE THEREOF |
| JP2013545740A (ja) * | 2010-11-10 | 2013-12-26 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | バニロイド受容体リガンドとしての置換された複素芳香族カルボキサミド誘導体および尿素誘導体 |
| US8497285B2 (en) | 2010-12-03 | 2013-07-30 | The Trustees Of The University Of Pennsylvania | Therapy of autoimmune colitis using a TIP60 inhibitor |
| FR2970967B1 (fr) * | 2011-01-27 | 2013-02-15 | Pf Medicament | Derives de type azaindazole ou diazaindazole comme medicament |
| CA2927009C (en) | 2013-10-21 | 2019-04-23 | Drexel University | Use of sting agonists to treat chronic hepatitis b virus infection |
| EP3556362A1 (en) * | 2018-04-16 | 2019-10-23 | Ecole Polytechnique Federale De Lausanne (Epfl) | Sting inhibitors |
| CN120004785A (zh) | 2018-07-03 | 2025-05-16 | 诺华制药股份有限公司 | 用于治疗与sting活性有关的疾病的化合物和组合物 |
-
2020
- 2020-12-30 JP JP2022540327A patent/JP2023509421A/ja not_active Revoked
- 2020-12-30 PY PY202002089151A patent/PY2089151A/es unknown
- 2020-12-30 WO PCT/US2020/067463 patent/WO2021138419A1/en not_active Ceased
- 2020-12-30 US US17/789,623 patent/US20230115274A1/en active Pending
- 2020-12-30 TW TW109146786A patent/TW202136255A/zh unknown
- 2020-12-30 CN CN202080097812.6A patent/CN115279770A/zh active Pending
- 2020-12-30 UY UY0001039005A patent/UY39005A/es unknown
- 2020-12-30 EP EP20849007.8A patent/EP4085061A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023509421A (ja) | 2023-03-08 |
| WO2021138419A1 (en) | 2021-07-08 |
| UY39005A (es) | 2021-07-30 |
| EP4085061A1 (en) | 2022-11-09 |
| CN115279770A (zh) | 2022-11-01 |
| TW202136255A (zh) | 2021-10-01 |
| US20230115274A1 (en) | 2023-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PY2089151A (es) | Compuestos y composiciones para tratar afecciones asociadas con la actividad de sting | |
| PY2026348A (es) | Compuestos y composiciones para tratar afecciones asociadas con la actividad de sting | |
| PY2089159A (es) | Compuestos y composiciones para tratar afecciones asociadas con la actividad de sting | |
| PY2060666A (es) | Compuestos y composiciones para tratar afecciones asociadas con la actividad de sting | |
| PY2157405A (es) | Compuestos y composiciones para el tratamiento de afecciones asociadas a la actividad del sting | |
| PY2201430A (es) | Compuestos y composiciones para tratar condiciones asociadas con la actividad de sting | |
| WO2020150417A3 (en) | Compounds and compositions for treating conditions associated with sting activity | |
| CO2019008932A2 (es) | Imidazo-quinolinas sustituidas como moduladores de nlrp3 | |
| EA201891565A1 (ru) | Соединения и композиции для лечения состояний, ассоциированных с активностью sting | |
| MX2018012249A (es) | Moduladores de nlpr3. | |
| WO2022133046A3 (en) | Compounds and compositions for treating conditions associated with sting activity | |
| MX2021009178A (es) | Composiciones de oligonucleotidos y metodos de las mismas. | |
| PY2301792A (es) | Compuestos y composiciones para tratar afecciones relacionadas con la actividad de sting | |
| CU20210094A7 (es) | Inhibidores del inflamasoma nlrp3 | |
| CL2024000385A1 (es) | Compuestos y composiciones para tratar condiciones asociadas con actividad de sting | |
| AR111693A1 (es) | Compuestos de 5-metil-1,3,4-oxadiazol-2-ilo con actividad inhibitoria de oga | |
| CL2025004052A1 (es) | Derivados pirazolo[3,2-c]piridinona, inhibidores egfr y/o her2; composición; uso en cáncer | |
| MA38380A1 (fr) | Inhibiteurs quinazoline de l'activation des formes mutantes du récepteur de croissance épidermique (egfr) | |
| EA201490279A1 (ru) | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения | |
| WO2022133098A3 (en) | Compounds and compositions for treating conditions associated with sting activity | |
| EA201991147A1 (ru) | ЛЕЧЕНИЕ ЗАБОЛЕВАНИЙ ЦЕНТРАЛЬНОЙ НЕРВНОЙ СИСТЕМЫ С ПОМОЩЬЮ СТИМУЛЯТОРОВ sGC | |
| EA202092719A1 (ru) | Бензолсульфонамидные соединения и их применение в качестве терапевтических средств | |
| MX2021003904A (es) | Compuestos y composiciones para el tratamiento de afecciones asociadas con la actividad del receptor apj. | |
| ECSP066457A (es) | 5-arilpirimidinas como agentes anti-cancer | |
| MX2018008157A (es) | Alfa-amino esteres de derivado de hidroxipropiltiazolidin carboxamida, y formas de sales y polimorfos cristalinos de estos. |